Khapzory: payments to doctors
Payments that named Khapzory as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $23K
- Providers
- 49
- Transactions
- 53
- Average per transaction
- $425
The per-transaction average — $425 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 49 providers the average total is $460, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Aurobindo Pharma USA, Inc. | $22,046 | 97.8% |
| Spectrum Pharmaceuticals Inc. | $504 | 2.2% |